Skip to main content
. 2022 Jul 11;12:919824. doi: 10.3389/fonc.2022.919824

Table 2.

Adverse events in treatment of adjuvant Lenvatinib after radical resection and their corresponding common terminology criteria for adverse events (CTCAE) grade.

Adverse events Adjuvant Lenvatinib (n = 57)
All Grade 1 Grade 2 Grade 3
Hypertension 20 10 7 3
PPES 13 7 5 1
Diarrhoea 19 9 8 2
Fatigue 15 9 6 0
Decreased appetite 16 7 9 0
Hypothyroidism 6 4 2 0
DILI 17 10 6 1
Others 10 7 3 0

PPES, palmar-plantar erythrodysesthesia syndrome; DILI, drug-induced liver injury.